(4-Chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol
![]() |
- $120 - $452
- Product name: (4-Chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol
- CAS: 1544673-40-6
- MF: C13H18BClO3
- MW: 268.54
- EINECS:
- MDL Number:MFCD18729959
- Synonyms:(4-Chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol;2-Chloro-5-hydroxymethylphenylboronic acid, pinacol ester;Benzenemethanol, 4-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
3 prices
Selected condition:
Brand
- Crysdot
- TRC
Package
- 250mg
- 1g
- 5g
- ManufacturerCrysdot
- Product numberCD12138353
- Product description(4-Chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol 95+%
- Packaging5g
- Price$452
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberC421938
- Product description2-Chloro-5-hydroxymethylphenylboronicAcid,PinacolEster
- Packaging250mg
- Price$120
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberC421938
- Product description2-Chloro-5-hydroxymethylphenylboronicAcid,PinacolEster
- Packaging1g
- Price$265
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Crysdot | CD12138353 | (4-Chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol 95+% | 5g | $452 | 2021-12-16 | Buy |
TRC | C421938 | 2-Chloro-5-hydroxymethylphenylboronicAcid,PinacolEster | 250mg | $120 | 2021-12-16 | Buy |
TRC | C421938 | 2-Chloro-5-hydroxymethylphenylboronicAcid,PinacolEster | 1g | $265 | 2021-12-16 | Buy |
Properties
Boiling point :391.6±37.0 °C(Predicted)
Density :1.16±0.1 g/cm3(Predicted)
pka :14.20±0.10(Predicted)
Density :1.16±0.1 g/cm3(Predicted)
pka :14.20±0.10(Predicted)
Safety Information
Symbol(GHS): |
![]() |
||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||||||||||
Precautionary statements: |
|